Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-22

Clinical Trial Update: The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy [NA]

View source ↗

Summary

This clinical trial update notes a randomized controlled study evaluating Shenqi Yishen Granules for IgA nephropathy, with the trial not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shenqi Yishen Granules

Snippet

Sponsor: Keda Lu | Conditions: IgA Nephropathy (IgAN) | NA | Status: NOT_YET_RECRUITING